4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-16-012691
CIK 0000875622operating
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 10:39 AM ET
Size
4.8 KB
Accession
0001062993-16-012691
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-12-08$49.54/sh−15,000$743,112→ 930,879 total
Footnotes (1)
- [F1]The selling price of $49.5408 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.20 to $50.13. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 10:39 AM ET
- Size
- 4.8 KB